<DOC>
	<DOCNO>NCT01724918</DOCNO>
	<brief_summary>The purpose study evaluate effect different intravenous dos ( IV ) new anti-epileptic drug ( AED ) call lacosamide continuous EEG ( electroencephalogram ) rhythm ( brain rhythm ) subject focal seizure tolerability dose patient . In addition , study assess effect IV lacosamide EKG ( electrocardiogram ) , test check problem electrical activity heart .</brief_summary>
	<brief_title>Lacosamide IV EEG/EKG ( LIVE ) Study</brief_title>
	<detailed_description>The impact antiepileptic drug EEG vary mark none . A small number AEDs also affect EKG . Lacosamide new AED selectively enhance slow inactivation voltage-gated sodium channel , result stabilization hyperexcitable neuronal membrane inhibition repetitive neuronal firing . Information lack effect lacosamide brain heart rhythm .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>1 . Subject inform give ample time opportunity think her/his participation give her/his write informed consent . 2 . Adult patient 1865 year 3 . Diagnosis focal epilepsy 4 . Continuous EEG video monitor 5 . Continuous EKG 6 . Active EEG show frequent spike , electrographic clinical seizure 1 . Subject IV access . 2 . Subject hemodynamically unstable . 3 . Previous use Lacosamide 4 . Primary generalize epilepsy 5 . Nonepileptic seizure 6 . No significant cardiac , renal hepatic disease 7 . No cardiac arrhythmia include heart block 8 . Subject pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>IV lacosamide</keyword>
	<keyword>focal epilepsy</keyword>
	<keyword>EEG</keyword>
	<keyword>EKG</keyword>
</DOC>